

Experience of using a complex preparation of hybrid polylactic acid in the correction of involutional changes in the skin
https://doi.org/10.33667/2078-5631-2025-8-106-110
Abstract
Material and methods. We observed 20 female patients aged 30 to 40 years (median 36.7±1.9 years) who came to the appointment with complaints of involutional changes in the facial skin (xerosis, decreased turgor, wrinkles). All patients underwent injection therapy procedures: Lenisna – facial contouring (temporal area, cheek area, chin), JuveLook – for the periorbital area. Efficiency was assessed using the SASSQ scale, qualitative characteristics of the skin (hydration, elasticity, severity of wrinkles).
Results of the study. The dynamics of the SASSQ scale was 45.6%, skin hydration increased almost 2 times, the elasticity index increased by 41.7%, the «severity of wrinkles» index decreased by 16.7%.
Conclusion. The use of Lenisna and JuveLook preparations containing PDLLA and HA allows to significantly improve the qualitative characteristics of the skin and restore tissue volume in case of involutional changes.
About the Author
A. R. NogerovRussian Federation
Nogerov Alim R., PhD Med, dermatovenerologist, cosmetologist; associate professor at Dept of Dermatovenerology and Cosmetology
Moscow
References
1. Alenichev A. Yu., Kruglova L.S., Fedorov S.M., Sharypova I.V. Evaluation of the effectiveness of microneedle RF therapy in the correction of involutional changes in the skin of the face and neck. Physiotherapist. 2017; 4: 4–13. (In Russ.).
2. Di Gregorio C, D’Arpa S. Therapeutic Use of Hyaluronic Acid Fillers in the Treatment of Corticosteroid-Induced Skin and Subcutaneous Atrophy. Dermatol Surg. 2016; 42 (11): 1307–1310.
3. Varani, J.; Dame, M.K.; Rittie, L.; Fligiel, S.E.; Kang, S.; Fisher, G.J.; Voorhees, J.J. Decreased collagen production in chronologically aged skin: Roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am.J. Pathol. 2006; 168: 1861–1868.
4. El-Domyati, M.; Attia, S.; Saleh, F.; Brown, D.; Birk, D.E.; Gasparro, F.; Ahmad, H.; Uitto, J. Intrinsic aging vs. photoaging: Acomparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp. Dermatol. 2002; 11: 398–405.
5. Zhukova O.V., Kruglova L. S., Frigo N.V. Method of aesthetic correction of involutional changes in facial skin. Clinical dermatology and venereology. 2018; 17 (2): 114–117. (In Russ.).
6. Yusova Zh. Yu., Kruglova L.S., Ektova T.V. Features of the use of stabilized hyaluronic acid in the dermis in the correction of involutional signs. Physiotherapist. 2015; 3: 48–55. (In Russ.).
7. Kruglova L.S., Surkichin S.I., Gryazeva N.V., Gres S.N. Distribution and degradation of a drug based on hyaluronic acid upon subdermal administration. Medical alphabet. 2021; 9: 67–71. (In Russ.).
8. Deglesne P-A, Arroyo R, Ranneva E, Deprez P. In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization. Clin Cosmet Investig Dermatol. 2016; 9: 41–53.
9. Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008; 10 (1): 35–42.
10. Vasanop V. Overview of botulinum toxin and fillers. In: Vasanop V, Poolkiat S, eds. Cosmetic dermatology and lasers. Dermatology Unit, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital; 2018: 169–184.
11. Ikonnikova E.V., Manturova N.E., Kruglova L.S. Delayed inflammatory reaction to hyaluronic acid fillers against the background of influenza-like illness. Russian Journal of Skin and Venereal Diseases. 2021; 24 (1): 93–100. (In Russ.).
12. Reuther T, Bayrhammer J, Kerscher M. Effects of a three-session skin rejuvenation treatment using stabilized hyaluronic acid-based gel of non-animal origin on skin elasticity: a pilot study. Arch Dermatol Res. 2010; 302 (1): 37–45.
13. Tammi R, Ripellino JA, Margolis RU, Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol. 1988; 90: 412–4.
14. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994; 102: 385–9.
15. Weissmann B, Meyer K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc. 1954; 76: 1753–7.
16. Asher B. Injection methods in cosmetology. Edited by B. Asher, translated from English. Moscow: MEDpress-inform, 2014. 584 p. (In Russ.).
17. Nikolis A, Enright KM. Evaluating the role of small particle hyaluronic acid fillers using micro-droplet technique in the face, neck and hands: a retrospective chart review. Clin Cosmet Investig Dermatol. 2018; 11: 467–475.
18. Edsman K, Nord LI, Ohrlund A, Lärkner H, Kenne AH. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2012; 38 (7 Pt 2): 1170–1179.
19. Ypiranga S, Fonseca R. Hyaluronic Acid Filler for Skin Booster on the Face. In: Issa MCA, Tamura B, eds. Botulinum Toxins, Fillers and Related Substances.Springer International Publishing; 2017: 1–10.
20. Ikonnikova E.V., Kruglova L.S., Golanova O.A. Possible adverse effects when working with fillers based on polylactic acid. Spa medicine. 2022; 2: 54–58. (In Russ.).
21. Ikonnikova E.V., Kruglova L.S. Formation of granulomas after the introduction of a dermal filler based on polycaprolactone (clinical case). Medical alphabet. 2021; (9): 94–96. (In Russ.). DOI: 10.33667/2078 5631 2021 9 94 96
22. Alijotas-Reig, J. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up / J. Alijotas-Reig, V. Garcia-Gimenez, M. Vilardell-Tarres. Dermatology. 2009; 219 4: 303–308.
23. Van Wouwe, P.; Dusselier, M.; Vanleeuw, E.; Sels, B. Lactide synthesis and chirality control for polylactic acid production. ChemSusChem 2016; 9: 907–921.
24. Lemperle, G.; Gauthier-Hazan, N.; Wolters, M.; Eisemann-Klein, M.; Zimmermann, U.; Duffy, D.M. Foreign body granulomas after all injectable dermal fillers: Part 1. Possible causes. Plast. Reconstr. Surg. 2009; 123: 1842–1863.
25. Anderson, J.M.; Rodriguez, A.; Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 2008; 20: 86–100.
26. Owczarczyk-Saczonek, A.; Zdanowska, N.; Wygonowska, E.; Placek, W. The immunogenicity of hyaluronic fillers and its consequences. Clin. Cosmet. Investig. Dermatol. 2021; 14: 921–934.
27. Bachour, Y.; Kadouch, J.A.; Niessen, F.B. The Aetiopathogenesis of late inflammatory reactions (LIRs) after soft tissue filler use: A systematic review of the literature. Aesthetic Plast. Surg. 2021; 45: 1748–1759.
28. Klopfleisch, R. Macrophage reaction against biomaterials in the mouse model – Phenotypes, functions and markers. Acta Biomater. 2016; 43: 3–13. Ignotz, R.A.; Massagué, J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337–4345.
29. Humble, G.; Mest, D. Soft tissue augmentation using sculptra. Facial Plast. Surg. 2004; 20: 157–163.
30. Palm, M.D.; Woodhall, K.E.; Butterwick, K.J.; Goldman, M.P. Cosmetic use of poly-l-lactic acid: A retrospective study of 130 patients. Dermatol. Surg. 2010; 36: 161–170.
31. Herrmann, J.L.; Hoffmann, R.K.; Ward, C.E.; Schulman, J.M.; Grekin, R. C. Biochemistry, physiology, and tissue interactions of contemporary biodegradable injectable dermal fillers. Dermatol. Surg. 2018; 44 (Suppl. S1): S19–S31.
32. Chen, S.Y.; Lin, J.Y.; Lin, C.Y. The back-and-forth method: A quick and simple technique for reconstitution of injectable poly-D, L-lactic acid. Arch. Aesthetic Plast. Surg. 2020; 26: 79–83.
33. Lin, C.Y.; Lin, J.Y.; Yang, D.Y.; Lee, S.H.; Kim, J.Y.; Kang, M. Efficacy and safety of poly-D, L-lactic acid micro-spheres as subdermal fillers in animals. Plast. Aesthet. Res. 2019, 6, 16.
34. Cenh, S.Y.; Lin, J.Y.; Lin, C.Y. Compositions of injectable poly-d, l-lactic acid and injectable poly-l-lactic acid. Clin. Exp. Dermatol. 2020; 45: 347–348.
35. Lorenc, Z.P.; Greene, T.; Gottschalk, R.W. Injectable poly-L–Lactic acid: Understanding its use in the current era. J. Drugs Dermatol. 2016; 15: 759–762.
36. Vleggaar, D.; Fitzgerald, R.; Lorenc, Z.P. Understanding, avoiding, and treating potential adverse events following the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J. Drugs Dermatol. 2014; 13 (Suppl. S4): s35–s39.
37. Vleggaar, D.; Fitzgerald, R.; Lorenc, Z.P. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: The positive impact of evolving methodology. J. Drugs Dermatol. 2014; 13 (Suppl. S4): s32–s34.
38. Alessio, R.; Rzany, B.; Eve, L.; Grangier, Y.; Herranz, P.; Olivier-Masveyraud, F.; Vleggaar, D. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation. J. Drugs Dermatol. 2014; 13: 1057–1066.
39. Bentov, I.; Reed, M.J. The effect of aging on the cutaneous microvasculature. Microvasc. Res. 2015; 100: 25–31
40. Oh, S.; Seo, S.B.; Kim, G.; Batsukh, S.; Son, K.H.; Byun, K. Poly-D, L–Lactic Acid Stimulates Angiogenesis and Collagen Synthesis in Aged Animal Skin. Int. J. Mol. Sci. 2023; 24:7986.
41. Oh S, So SB, Kim G, Batsuh S, Song KH, Byun K. Poly-D, L-lactic acid stimulates angiogenesis and collagen synthesis in aging animal skin. Int J Mol Sci. 2023 Apr 28; 24 (9):7986.
Review
For citations:
Nogerov A.R. Experience of using a complex preparation of hybrid polylactic acid in the correction of involutional changes in the skin. Medical alphabet. 2025;(8):106-110. (In Russ.) https://doi.org/10.33667/2078-5631-2025-8-106-110